Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and pelvic organ prolapse, kidney stone, benign prostatic hyperplasia (BPH) and end stage renal disease (ESRD). According to WHO, more than 190 million patients suffer from chronic renal failure and undergo renal dialysis and over 220 million males suffer from diseases associated with prostate glands such as swelling that results in blockage of the flow of urine through the body. This rising incidences of kidney and urology diseases has shifted the inclination of physicians towards use of highly advanced nephrology and urology devices that significantly reduce treatment and recovery time.
The major driving factor for this market is the growing aging population and prevalence of chronic kidney diseases. Innovation in urology devices and an increase in healthcare expenditure will also supplement the growth of this market. However, the high cost associated with these devices hinders the growth of this market. Growing awareness about benefits such as reduced treatment and recovery time among renal disease patients is fuelling the demand for nephrology and urology devices.
Nephrology and Urology Devices market by Type
Nephrology and Urology devices market is segmented by type into dialysis equipment, urinary stone treatment devices, urinary incontinence & pelvic organ prolapse devices, endoscopy devices and benign prosthetic hyperplasia treatment devices. Dialysis equipment is the largest segment of the market due to rising incidences of chronic kidney diseases.
Nephrology and Urology Devices market by Geography
Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. Currently, Europe is the largest region in the nephrology and urology devices market with leading dialysis and sacral neurostimulation market. North America is the second largest market and is expected to expand its sacral neurostimulation market in the coming years.
Baxter International, C.R.Bard, Fresenius Medical Care, Nikkiso Co. Ltd, Dornier Medtech is some major key players in this market. Product launch, merger and acquisition, and research and development are the competitive strategies adopted by these players. In Sep 2013, Baxter acquired Gambro, a medical device company. This acquisition expands Baxter’s dialysis product portfolio and its geographic presence in the dialysis business.
Porter’s Five Forces model reveals that the bargaining power of suppliers is high as suppliers are producing highly differentiated products. High switching cost for these differentiated products lowers the bargaining power of buyers. However, high initial investment is required to startup these device-manufacturing units. This leads to a minimal threat from new entrants. The market is highly fragmented and a number of players are coming up with new innovative products, which intensify the competition in the market. Key players and their strategies are identified and analyzed to develop a market entry and expansion strategy. Driving and limiting factors affecting the growth of nephrology and urology devices market are discussed in the report.
KEY MARKET SEGMENTS
Market by Type
MARKET BY GEOGRAPHY
Gastroparesis Drugs Market by Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections), Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, and Post-Surgical Gastroparesis), and End User (Hospitals, Pharmacies, Clinics, and E-commerce) - Global Opportunity Analysis and Industry Forecast, 2017-2023
The global gastroparesis market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the normal spontaneous movement of the muscles of the stomach. It restricts the ...
November 2017 | $5370 |View Details>>
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the ...
November 2017 | $4880 |View Details>>
In this report, the global Interleukin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue ...
November 2017 | $2900 |View Details>>
In this report, the global Nerve Repair Biomaterial market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, ...
November 2017 | $2900 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research